Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Non-linear Measures of Gait Adaptability in Multiple Sclerosis - Sensitivity and Neurological Correlates

View ORCID ProfileMG Panisset, LE Cofré Lizama, L Peng, MP Galea
doi: https://doi.org/10.1101/2022.07.06.22277289
MG Panisset
aDepartment of Medicine, The University of Melbourne, Clinical Sciences Building 601, Royal Parade, Parkville, VIC 3050 Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for MG Panisset
  • For correspondence: mpanisset{at}unimelb.edu.au
LE Cofré Lizama
aDepartment of Medicine, The University of Melbourne, Clinical Sciences Building 601, Royal Parade, Parkville, VIC 3050 Australia
bSchool of Allied Health, Human Services and Sport, La Trobe University, Bundoora, VIC 3086 Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
L Peng
cSchool of Mathematics and Statistics, The University of Melbourne, Peter Hall Building, Parkville, VIC 3050 Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MP Galea
dDepartment of Rehabilitation, Royal Melbourne Hospital Royal Park Campus, 34-45 Poplar Rd, Parkville, VIC, 3052 Australia
eAustralia Australian Rehabilitation Research Centre, Royal Park Campus, 34-45 Poplar Rd, Parkville, VIC, 3052 Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Multiple sclerosis (MS) is the leading cause of non-traumatic disability among young and middle-aged adults. People with MS (pwMS) rate walking and mobility as their highest priority for both research and symptom management. Given the importance of early initiation of disease-modifying therapeutics (DMTs) to minimize long-term disability, tools to identify early disease activity are needed. Traditional measures of disability, the Expanded Disability Status Scale (EDSS) and gait speed tests demonstrate poor reliability and responsiveness in cases with minimal disability. Nonlinear measures of gait, Local dynamic stability (LDS), Complexity (sample entropy) and Regularity (autocorrelation), measured in laboratory settings is sensitive to subclinical gait deterioration in people with MS (pwMS). These measures have not been tested in a clinical setting using wearable sensors.

Methods Gait metrics were calculated in MatLab from inertial data collected from 59 pwMS (EDSS 0-4) and 23 age- and sex-matched healthy controls (HC) during a 5-minute walk. We aimed to provide known-groups validation of non-linear gait measures and compare sensitivity of LDS from sensors placed at sternum and sacrum in pwMS (ROC analysis). Associations of gait metrics with disability, Kurtzke Functional System scores and 3T MRI segmental brain volumes were examined.

Results Most sternum-derived LDS measures detected significant differences between HC and pwMS (EDSS0-1) with moderate to large effect sizes (η2=.100-305), while the effect sizes for sacrum-derived LDS were lower (η2=.104-.166). Sternum3D best distinuished EDSS0-1 from HC whereas the effect size was lower for gait speed (η2=.104). Sternum Instability-3D showed strongest correlation with pyramidal dysfunction (rs=.455, p<.001). Sensory dysfunction correlated significantly with Regularity in the vertical plane from both sensors, while cerebellar dysfunction was significantly associatesd with sacrum Regularity in the saggital plance (r=-.343, p=.008) and brainstem dysfunction with Complexity in the frontal plane (r=-.343, p=.008).

Conclusion Sternum-derived LDS measures were more sensitive than Sacrum-derived measures. Correlations with clinical and morphological brain measures support the validity of walking deterioration as reflective of neurodegeneration in subcortical grey matter. The current findings of high sensitivity in non-disabled cases, as well as the clinical feasibility and relatively low costs, support the utility of these measures as a supplementary clinical assessment tool.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

Funding: This work was supported by Multiple Sclerosis Research Australia [18-0436].

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study was approved by the Human Research Ethics Committee at the Royal Melbourne Hospital (HREC2019.093).

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All data produced in the present study are available upon reasonable request to the authors

  • Abbreviations

    LDS
    Local Dynamic Stability
    AP
    Anteroposterior
    ML
    Mediolateral
    VT
    Vertical
    CoM
    Center of Mass
  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
    Back to top
    PreviousNext
    Posted July 10, 2022.
    Download PDF

    Supplementary Material

    Data/Code
    Email

    Thank you for your interest in spreading the word about medRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    Non-linear Measures of Gait Adaptability in Multiple Sclerosis - Sensitivity and Neurological Correlates
    (Your Name) has forwarded a page to you from medRxiv
    (Your Name) thought you would like to see this page from the medRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    Non-linear Measures of Gait Adaptability in Multiple Sclerosis - Sensitivity and Neurological Correlates
    MG Panisset, LE Cofré Lizama, L Peng, MP Galea
    medRxiv 2022.07.06.22277289; doi: https://doi.org/10.1101/2022.07.06.22277289
    Twitter logo Facebook logo LinkedIn logo Mendeley logo
    Citation Tools
    Non-linear Measures of Gait Adaptability in Multiple Sclerosis - Sensitivity and Neurological Correlates
    MG Panisset, LE Cofré Lizama, L Peng, MP Galea
    medRxiv 2022.07.06.22277289; doi: https://doi.org/10.1101/2022.07.06.22277289

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • Neurology
    Subject Areas
    All Articles
    • Addiction Medicine (349)
    • Allergy and Immunology (668)
    • Allergy and Immunology (668)
    • Anesthesia (181)
    • Cardiovascular Medicine (2648)
    • Dentistry and Oral Medicine (316)
    • Dermatology (223)
    • Emergency Medicine (399)
    • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
    • Epidemiology (12228)
    • Forensic Medicine (10)
    • Gastroenterology (759)
    • Genetic and Genomic Medicine (4103)
    • Geriatric Medicine (387)
    • Health Economics (680)
    • Health Informatics (2657)
    • Health Policy (1005)
    • Health Systems and Quality Improvement (985)
    • Hematology (363)
    • HIV/AIDS (851)
    • Infectious Diseases (except HIV/AIDS) (13695)
    • Intensive Care and Critical Care Medicine (797)
    • Medical Education (399)
    • Medical Ethics (109)
    • Nephrology (436)
    • Neurology (3882)
    • Nursing (209)
    • Nutrition (577)
    • Obstetrics and Gynecology (739)
    • Occupational and Environmental Health (695)
    • Oncology (2030)
    • Ophthalmology (585)
    • Orthopedics (240)
    • Otolaryngology (306)
    • Pain Medicine (250)
    • Palliative Medicine (75)
    • Pathology (473)
    • Pediatrics (1115)
    • Pharmacology and Therapeutics (466)
    • Primary Care Research (452)
    • Psychiatry and Clinical Psychology (3432)
    • Public and Global Health (6527)
    • Radiology and Imaging (1403)
    • Rehabilitation Medicine and Physical Therapy (814)
    • Respiratory Medicine (871)
    • Rheumatology (409)
    • Sexual and Reproductive Health (410)
    • Sports Medicine (342)
    • Surgery (448)
    • Toxicology (53)
    • Transplantation (185)
    • Urology (165)